Northern Fish Products, Inc.
Letter data
- Company
- Northern Fish Products, Inc.
- Recipient
- Northern Fish Products, Inc. | United States
- Issue date
- 2018-02-28
- Posted date
- Not available
- FDA office
- United States
- Subject
- Not available
- Product
- Not available
- CMS ID
- 514554
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Northern Fish Products, Inc.
MARCS-CMS 514554 —
February 28, 2018
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Recipient:
Northern Fish Products, Inc.
United States
Issuing Office:
United States
Seattle District Office
22215 261h Avenue SE, Suite 210
Bothell, Washington 98021
February 28, 2018
CERTIFIED MAIL
RETURN RECEIPT REQUESTED
Ross R. Swanes, President
Northern Fish Products, Inc.
P.O. Box 9615
Tacoma, Washington 98409
Dear Mr. Swanes:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter SEA 17-12, dated April 25, 2017. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Miriam R. Burbach
District Director
Program Division Director
Content current as of:
03/05/2018